Sera from mice infected with Plasmodium yoelii or Plasmodium berghei and given endotoxin contained nonspecific mediators which killed both species of parasite and tumor cells in vitro. The sera resembled tumor necrosis sera obtained from mice given macrophage-activating agents such as Propionibacterium acnes (formerly designated Corynebacterium acnes) or Mycobacterium bovis BCG and then endotoxin. Cytotoxicity developed parallel to parasite killing activity and indicated that macrophages were activated. Activation occurred sooner with P. berghei, which is lethal, and serum activity remained on a plateau until the mice died. In nonlethal P. yoelii infections, activation was related to the course of parasitemia. Endotoxin given to mice infected with P. yoelii caused an immediate decrease in parasitemia, presumably through the release of parasite killing factors. The extent of the decrease depended upon the time of administration. No immediate drop in the parasitemia caused by P. berghei was observed at any time.
Sera from mice infected with Plasmodium yoelii or Plasmodium berghei and given endotoxin contained nonspecific mediators which killed both species of parasite and tumor cells in vitro. The sera resembled tumor necrosis sera obtained from mice given macrophage-activating agents such as Propionibacterium acnes (formerly designated Corynebacterium acnes) or Mycobacterium bovis BCG and then endotoxin. Cytotoxicity developed parallel to parasite killing activity and indicated that macrophages were activated. Activation occurred sooner with P. berghei, which is lethal, and serum activity remained on a plateau until the mice died. In nonlethal P. yoelii infections, activation was related to the course of parasitemia. Endotoxin given to mice infected with P. yoelii caused an immediate decrease in parasitemia, presumably through the release of parasite killing factors. The extent of the decrease depended upon the time of administration. No immediate drop in the parasitemia caused by P. berghei was observed at any time. Early administration of endotoxin prolonged survival; late administration accelerated death. Passive transfer of rabbit tumor necrosis serum to infected mice decreased the parasitemia caused by P. yoelii but not that caused by P. berghei. Other components of the immune response appeared to act together with these soluble mediators to eliminate P. yoelii; they may be absent or suppressed in infections with P. berghei.
The susceptibility of malarial parasites to nonspecific inhibition by various immunopotentiating agents is well documented (2, 3, 5, 7, 12, 15) , and there is good evidence that the products of activated macrophages may play a role in this protection. It is also well established that the administration of endotoxin to animals which have already received conventional immunostimulants such as Propionibacterium acnes (formerly designated Corynebacterium parvum) or Mycobacterium bovis BCG induces the release into the serum of a large number of soluble mediators of macrophage origin, including tumor necrosis factor, a substance which is cytotoxic for some tumor cell lines in vitro (1, 6, 13) . Clark and colleagues (4) reported that tumor necrosis serum protects mice infected with Plasmodium vinckei subsp. petteri from death, and we have shown that such serum inactivates malarial parasites in vitro (21) . Furthermore, Plasmodium yoelii, its lethal variant, and Plasmodium berghei were found to be equally susceptible to inactivation in vitro. We have also shown that sera from mice given endotoxin at various times after infection with any of these parasites inactivated P. yoelii in vitro, and we have argued that the production of this parasite killing activity reflects macrophage activation occurring during infection (21) .
We now confirm that sera of the kind previously shown to kill parasites are also cytotoxic for tumor cells. A study of the effect of tumor necrosis serum (TNS) on parasites in vivo revealed a striking difference between the lethal and nonlethal infections, both in response to the administration of endotoxin during infection and in susceptibility to injections of rabbit TNS. proportion of the total amount of label incorporated, determined after the cells were lysed with 0.5% sodium dodecyl sulfate. The serum titer was defined as the reciprocal of the highest dilution that released 15% more isotope than the normal serum control.
RESULTS
To confirm that the kind of serum which killed parasites in vitro nonspecifically (21) and which should have contained tumor necrosis factor did indeed kill tumor cells, we performed cytotoxic assays with L929 cells. Confirming the results of others (1, 11), we found that at dilutions of more than 1/100, only sera from mice that had received both a macrophage-activating agent and LPS were cytotoxic for L929 cells. This assay was several thousand times more sensitive than measurement of parasite killing. Potent TNS samples, for instance, had titers of 8,000 to 24,000 against tumor cells but rarely killed parasites significantly in vitro if diluted more than 1/ 10 (21).
Cytotoxicity for tumor cells of endotoxin-induced sera from mice with malaria. Since we found that sera taken from mice infected with P. yoelii or P. berghei and given LPS could be cytotoxic for parasites in vitro, a further series of samples was obtained from mice given LPS at different times after infection, and cytotoxic activity against L929 cells was titrated. Again, no activity was detected in sera obtained at any stage of infection from mice infected with either parasite unless the mice were given LPS. Sera from mice given LPS at the height of infection showed marked activity against L929 cells, with titers of the same order as those of mouse TNS. Like parasite killing activity, cytotoxicity for tumor cells varied with parasitemia at the time of administration of LPS. Cytotoxicity appeared sooner and rose faster in mice infected with P. berghei, reaching a plateau after about 7 days (Fig. 1) . With P. yoelii, cytotoxicity did not reach a peak until after about 10 days; then it remained high as long as the parasitemia was high and disappeared when the parasites were cleared from the blood. For comparison, the previously reported results of parasite killing assays of sera from similar groups of mice are included (21) . The cytotoxic activities against tumor cells and against parasites induced in sera by endotoxin given during infection follow a very similar time course.
Effect on parasitemia of LPS administration during infection. Since the injection of LPS into infected mice induced the release into the sera of cytotoxic factors which killed parasites in vitro, we examined the blood of these mice for changes in the numbers of parasites. In each series of experiments, six mice were each given one injection of 5 day after infection, and the course of parasitemia was followed and compared with that of the controls (Fig. 2) . As was expected from the above findings, parasitemia was significantly reduced after the injection of LPS on certain days, but the time of this effect and its magnitude varied with the time of administration and the species of parasite.
With P. yoelii ( Fig. 2A) , there were three phases of infection during which the injection of LPS gave different responses. In the first phase, which lasted for the period of exponential multiplication, an immediate but transient effect was observed. One day after the injection of LPS, the parasitemia was lower than it was in the controls, but the relative depression disappeared and parasite numbers returned to control levels within 7 to 8 days. Even within the first week, however, we observed that the later the administration of LPS, the greater the effect. Thus, when LPS was given at day 7 (data not shown) or day 5, the next day the parasitemia was lower than it had been at the time of injection; it was even lower than that of the controls, which had multiplied meanwhile. When LPS was given at day 3, there was no actual decrease in the parasitemia by next day, but the rate of parasite multiplication was inhibited. In the second phase of the infection, which lasted from about day 8 to day 14, administration of LPS accelerated the clearance of the parasites. After day 14, there was a third phase, in which parasites were already disappearing from the blood of controls and the injection of LPS had no effect; the parasites continued to be cleared at the same rate as in the controls.
By contrast, during the first week of infection with P. berghei, we observed that the earlier the administration of LPS, the greater the difference in parasitemia (not the next day but later, after a delay) and the better the protection in terms of prolongation of survival time (Fig. 2B) . Thus, when LPS was given at day 3 or 5, there was no immediate effect on the parasitemia, but after day 4 or 5, a transient drop occurred and the treated mice died later than the controls. However, when LPS was given after day 7, when the mean parasitemia was over 20%, most of the mice died within 48 h. In the typical experiment illustrated, the mean survival times were 11.0 days for controls and 9.2 days for the group given LPS at day 7; for the mice given LPS at day 3 or 5, the mean survival time was 18.8 days (P < 0.05) and 16 active against both parasites and tumor cells by in vitro assays [ Fig. 1] ), experiments were done to see whether both species of parasite were equally sensitive to TNS in vivo. Mice were given a single injection of rabbit TNS and 104 parasites of the nonlethal strain of P. yoelii, and the course of the parasitemia was compared with that for controls. The means of results obtained with sera from four rabbits showed that administration of TNS caused a small but significant effect (Fig. 3) . The development of parasitemia was delayed by about 2 days, and the level remained below that of the controls until the end of the first week. In another experiment, in which, on the average, only three parasites per mouse were injected, all four controls became infected, but three of the four treated mice remained negative. Parasites were not seen in the blood of the remaining mouse until day 9, 4 days after they were seen in the controls. Although the amount of TNS used largely suppressed infection, it did not wholly prevent the multiplication of even this very small inoculum.
When, however, one injection of TNS was given to mice 14 days after infection with P. yoelii, the parasites were cleared more rapidly than they were in the controls. The rate of clearance was linear with time when the mean parasitemia was expressed as a percentage of that of the controls (Fig. 4) . In two experiments with different samples of TNS, the parasitemia in the control mice did not decrease spontaneously until about day 18, when the parasitemia of the treated groups had decreased to about 1% that of the controls.
Thus, one injection of TNS given at the start or in the middle of infection had a pronounced effect on P. yoelii in vivo.
Effect of repeated injections of TNS. When TNS was injected at the start of infection with 104 P. yoelii parasites and then at 2-to 3-day intervals thereafter, the development of parasitemia was greatly diminished. Fewer than 0.1% of the erythrocytes were infected in the first 2 weeks, but blood smears were not completely negative until about the time when the infection cleared spontaneously in the controls. Three batches of TNS were tested with the same result; the course of a typical experiment is shown in Fig. 5A . By contrast, repeated injections of three different batches of TNS had no detectable effect on similar numbers of P. berghei parasites, and the mean day of death was not different from that of the controls (Fig.  SB) . The lethal variant of P. yoelii was intermediate in its susceptibility to TNS in vivo (Fig.  5C ). Although the parasitemia was significantly lower than that of the controls, it was decreased Effect of TNS on P. berghei infection initiated with fewer parasites. Since repeated injections of TNS did not affect the parasitemia of mice receiving 104 to 105 P. berghei parasites, we tried to determine if TNS inhibited the replication of a smaller inoculum. Groups of mice were given TNS and then infected with different numbers of parasites, ranging from 100 to 1 per mouse (as determined retrospectively from our calibration curve), and their parasitemias were compared with those of controls (Fig. 6) . With as few as 10 parasites per mouse, no difference was observed in parasitemias or the mean day of death. A small effect was apparent, however, in the group receiving one parasite per mouse; parasitemia was delayed by about a day and the mean day of death was prolonged significantly to 18 .0 days, compared with 12.7 days for the controls (<0.05 by Student's t test).
Thus, although the in vivo susceptibility to TNS of P. berghei is clearly very different from that of P. yoelii, the difference appears to be quantitative in that an effect was detected against very small numbers of P. berghei parasites. However, even then the mice did not survive. DISCUSSION The differences among the three kinds of malarial parasite revealed by their grades of susceptibility to the inhibitory effects of TNS in vivo are of great interest since they correlate with virulence. The nonlethal strain was the most susceptible, but repeated injections of TNS were necessary to prevent the parasitemia from increasing. P. vinckei subsp. petteri appeared to be more sensitive, since two injections of mouse TNS were sufficient to protect mice from death (4), but it is possible that mouse TNS is more potent than rabbit TNS or that rabbit TNS is more quickly eliminated. Repeated administration of rabbit TNS delayed the parasitemia caused by the lethal variant of P. yoelii only slightly but did protect most mice from death, whereas P. berghei was completely resistant. Although both P. berghei and the lethal variant of P. yoelii kill mice (indeed, the latter multiplies faster and kills sooner), P. berghei is more resistant to immunological control in general. It is harder to protect mice against P. berghei infection, both specifically, by vaccination (18) or passive transfer of specific antiserum (16) as P. yoelii, P. vinckei, Babesia microti, and B. rodhaini (2, 3) but protect only a proportion of mice of some strains against P. berghei (14) . Interestingly, another macrophage product, hydrogen peroxide, has also been found to be more active in vivo against P. yoelii than against P. berghei (H. M. Dockrell and J. H. L. Playfair, personal communication).
All three kinds of parasites, however, are killed in equal numbers by TNS in vitro, which suggests that other components of the immune response may act with TNS in vivo to eliminate susceptible parasites. Changes were first apparent about 14 days after infection with P. yoelii, when one injection of TNS induced rapid clearance of parasitemia (Fig. 4) . Before then, repeated injections reduced parasitemia by about 10-fold but did not eliminate the parasites (Fig. 5) . Furthermore, endotoxin had the greatest effect on parasitemia at about this time (Fig. 2) . It is theoretically possible that endotoxin acts by depleting a factor in mice essential for parasite multiplication and that multiplication of P. berghei, unlike that of P. yoelii, is independent of such a factor. But since the injection of TNS itself did not affect P. berghei either, it seems more likely that endotoxin acted by stimulating activated macrophages to release the kind of cytotoxic TNS products to which P. yoelii is susceptible and P. berghei is resistant (and which were shown to be present by the L-cell cytotoxicity assay). We do not know that the factors that killed these parasites are the same as those that killed tumor cells; indeed, tumor necrosis factors from mice and rabbits are known to have different molecular structures. Nevertheless, both parasite killing activities and tumor killing activities appeared together, and both were clearly the result of a strong macrophage activation.
The discrepancy between the susceptibility of P. berghei to TNS in vitro and its resistance to TNS in vivo could have several explanations, such as inactivation of TNS, sequestration in some site where the parasites are relatively protected, or failure to activate some other necessary host response. Compared with P. yoelii infections, very little proliferation of T cells occurs in P. berghei infections (9), and P. berghei induces both greater suppression of immunological responses (10) and the production of autoantibodies against lymphocytes that might perhaps block the function of critical lymphocyte subpopulations (17) . Among the thymus-dependent responses in malaria are splenomegaly (19) , spleen macrophage recruitment (24) , and blood monocytosis (8) . The spleen may play an important role: in splenectomized mice, the course of P. yoelii infection was not always affected by repeated injections of TNS (unpublished data). Although enhanced erythropoiesis, regulated by T cells, may play a role in resolving nonlethal infections (23) , no enhancement of reticulocyte numbers was detected in infected mice treated with TNS (unpublished data). Nor does TNS appear to act by enhancing monocytosis (unpublished data).
The fatal outcome of P. berghei infection is clearly not due to a failure of macrophage activation or to a lack of the capacity to release toxic factors (Fig. 2) . However, tumor cell cytotoxicity was not detected in sera taken at any stage of infection with P. berghei or P. yoelii (or P. vinckei subsp. petteri [4] ) unless the mice were given endotoxin. ILl (lymphocyte activating factor), another macrophage product which probably amplifies specific protective immunity, is also only detectable in sera after infected mice are given endotoxin (4) . If these mediators play a role during infection, then an endogenous trigger must cause their release. Perhaps parasite products or some host factors present during infection act like endotoxin (5a) but, rather than inducing a sharp burst, induce the release of only small amounts of the cytotoxic factors locally in the liver or spleen, where intraerythrocytic parasites are in close proximity to activated macrophages. Such active mediators are likely to be quickly inhibited or removed from the circulation.
Weidanz and Grun (23) have demonstrated that malarial parasites differ in the capacity to be controlled by antibody-independent mechanisms. An example of such a mechanism is provided by our findings that cytotoxic products of activated macrophages are not equally active against all kinds of malarial parasites in vivo.
